Dr. Madigan is the founder of Vida Pharmacal, a human and veterinary pharmaceutical company. The company’s focus is development of novel therapeutics to address emerging parasitic diseases in both humans and animals. Dr. Madigan’s work includes filing the first veterinary drug patent for anti-T. cruzi activity in dogs and conducting pioneering research in studying the curative effects of a drug combination in human heart cells infected with Chagas disease. He is also developing serologic techniques to diagnose T. cruzi infection in dogs.
Dr. Madigan is the principal scientist in the Canine Chagas Treatment Study, Lackland Air Force Base, San Antonio, TX—research into treatment of canine Chagas disease in Unites States Army military working dogs. He is also the director of The Animal Hospital of Smithson Valley in Spring Branch, TX, where he serves as Chief Medical Officer and coordinator for small animal medicine and surgery. He is a member of the Texas Chagas Task Force, Centers for Disease Control, and University of Texas Health Science Center, San Antonio, TX, as the veterinary lead for canine Chagas disease in Texas. The Task Force increases public awareness of Chagas disease by working with healthcare providers, entomologists, marketing, and the public. Dr. Madigan and his family reside in the Texas Hill Country with a pug named Buda, a golden retriever Daisy, and a GSP named Rip.